The objective of this study was to assess Community health workers (CHW) 
Introduction
Noncompliance to World health organization (WHO) injection guideline leads to unsafe injection and poor waste management that leads to increasing direct health care cost and causing millions of deaths. Non compliance causes various diseases acquired from contaminated injection, inappropriate injection technical performance and poor handling of biological waste from injection procedures (Nilsson et al., 2013 , WHO, 2010 . Non compliance to WHO injection guideline is public health issue that need to be dressed in order to prevent transmission of blood born infections during this era of increasing use of informal health care workers, particularly community health workers (CHW) to provide injectable medication (Nilsson et al., 2013 , WHO, 2010 Olawo et al., 2013; Brunie et al., 2011 ) . Implementing safe injection procedure is one of the major challenges that developing countries health care service providers are facing (Gyawali et al., 2013) . Unsafe injection is the one that lead to transmission of different types of pathogens, including bacteria, parasites, viruses, bacteria and fungi and also cause non-infectious adverse events such as abscesses and toxic reactions. (WHO, 2010; Pruss et al., 2005) .
In 2010, in sub-saharan Africa alone, non compliance to injection guidelines contributed to 1.9 million cases of HIV infection, which is 17% of new HIV infection due to unsafe injection procedures (Nilsson et al., 2013) . Health care workers (HCW) in sub-Saharan Africa are more exposed to waste that are highly infectious including contaminated needles, sharps, and syringes that causing them annual estimated infection of 16,000 of HCV infections, 66,000 HBV and 1,000 HIV infections (Pruss-Ustun et al., 2005; WHO, 2010; Nilsson et al., 2013) . In Many African nations waste is burn in open places exposing surrounding people with hazardous substances (Nilsson et al., 2013) . The recommended solution to address the problem of non compliance is to involve all necessary stakeholders in the training and appropriate educational program. Effective management policy and active participation of stakeholders responsible for injection activities can help reduce unsafe injection practice effectively (Gyawali et al., 2013). All governments, health professionals, patients and communities in general are responsible to ensure safety for injection procedures (WHO, 2010) .
WHO recommends safe injection procedures in its guideline manual as the best practice for safe injection. Unfortunately almost half of the developing nations do not follow WHO guideline for safe injection procedures (Nilsson et al, 2013; WHO, 2010) . The guideline indicates how to conduct safe injection, how to dispose syringes, sharps and other health care waste (WHO, 2010). Best injection practice as dictated in the injection guideline by WHO is the one that is performed aiming at protecting patients, health workers and the community from contaminated post-injection waste (WHO, 2010) . WHO Best infection control practices for injections advocate for use of new sterile single-use injection equipment for each procedure, while HCWs are required to discard any injection package that is damaged (WHO, 2008 , WHO, 2010 , WHO, 2015 . Providers are required to anticipate and take measures to prevent needle stick by preparing and preventing sudden patient movement and avoiding recapping and other manipulation of needle or if necessary use a single-handed scoop recapping technique (WHO, 2015) . Providers are required to collect used injection equipment at the point of use in a sharps container that has no leakages and is puncture proof that can be sealed-shut during transportation to disposal site (WHO, 2015). The guideline for safe injection put emphasis on separation of infectious waste from non-infectious waste, sharp from non-sharp and be disposed at different containers while avoiding overfill of the waste collecting container to reduce risk of exposure to needle stick injury (NSI) Tanzania has started using CHW to administer injectable medication as community based services to increase access of injectable contraceptive since 2015. This is one of national efforts to ensure availability and accessibility of injectable contraceptive to reduce unmet needs of family planning.
Tanzania is one of many African countries that have high prevalence of HIV infection (Nilsson et al., 2013 . Recently study conducted in Tanzania indicates that health care workers have inadequate knowledge of risks associated with unsafe injection practice and postinjection waste (Nilsson et al., 2013) . The study also indicated that 46% of health care workers had NSI for the past five years, while 50% were exposed to blood in their mucus membrane or skin wounds (Nilsson et al., 2013) . Despite all injection activities conducted by the community health workers in the country, few information is available on CHW compliance to WHO guideline on safety, waste disposal and technical perceptive of intramuscular injection. While few data on unsafe injection is available, unsafe injection will continue to transmit blood bone diseases in Tanzania. If this situation is not brought to the control unsafe injection practices will continue to fuel blood borne diseases such as Ebola, malaria, Marburg viruses and hemorrhagic fevers in Africa (WHO, 2015).
We planned to evaluate the compliance to WHO injection guideline of a paid community health worker employed by a non-government organization that was trained and supervised by Ministry of health. This Study has assessed the safety infection prevention and technical performance procedures as WHO guidelines elements for safe injection during CHW's performance of intramuscular injection in the community setting at Kilombero district in southern Tanzania.
Methodology
About 35 CHWs with ordinary level secondary education were trained for one month to administer injectable contraceptive. The trained CHWs were later deployed to the community to administer intramuscular injection of medroxyprogesterone acetate as part of family planning program in Kilombero district, southern part of Tanzania.
The cross sectional descriptive study design was used to collect data. The structured direct observation checklist form was used to collect information of injection processes and safety steps. The checklist was prepared using guidelines of the Tanzanian Ministry of Health adopted from WHO guidelines for safe injection (Nilsson et al., 2013; WHO, 2010 , Tanzania, 2004 . About 12 registered reproductive health nurses participated to conduct direct observation of injection steps being performed and filled direct observational checklist form. Nurses direct observed and filled the direct observation form for CHWs who were administering injection for at least 24 injections for each CHW for the period of June-2015 to May 2015. The close-ended checklist of injection performance steps were defined as 0 for non-compliance and 1 as compliance to safe step of intramuscular injection respectively. The first part of checklist form was the demographic characteristic including age and sex of CHW performing the injection steps. The second section was infection prevention steps conducted by CHW while using syringes, needles, sharps, pads and other blood contaminated materials and third one is recommended safe steps of injecting the DMPA. The injection observation was conducted at setting convenient for client either at client's home or at CHW's home, nearest health facility or other places.
Ethical consideration
The study was approved by the Medical Research Coordinating Committee of National Institute for Medical Research (NIMR) while research clearance was obtained from Ifakara health Institute and I formed consent was sought from women receiving injection.
Data analysis
EpiData software was used to develop data entry screen for processing of direct observation checklist. Data analysis was performed using Stata version 13 (College Station, Texas). Variables were categorized as: Age and sex of CHW, settings of giving injection, Infection prevention and intramuscular injection technical performance compliance procedures. Frequencies tables and cross tabulations were used to determine compliances to WHO recommended safe intramuscular steps and associations between variables. The infection prevention steps observed were; (1) washing hands well with soap and water or apply alcohol hand rub on the hands, (2) drying hands with a clean single use towel or let them air dry, (3) Opens (appropriate size) sterile package for syringe/needle, (4) Do not recap needle to avoid needle stick injury, (5) Cleans injection site with dry swab (without using any antiseptic), (6) washing hands with soap and water or apply alcohol hand rub on both hand after the procedures (7) , Do not massage injection site, (8) Instructs the client not to massage after injection to avoid introducing infection to injection site, and (9) discards the used syringe and needle into the safety-box (WHO, 2015, Hunter, 2007). Intramuscular injection technical performance compliance steps observed are: (1) checks the vial for content, dose, and expiration date, (2) mix the contents by rolling bottle between palms or shakes gently to homogenize the solution, (3) correctly filling of syringe with contents of the bottle, (4) expels air from syringe without pushing any of the DMPA out, (5) Inserts needle deep into the deltoid muscle, (6) aspirates to ensure needle is not in a vein, (7) For categorical data, the proportional and confidence interval are presented with nonoverlapping confidence suggesting a significant difference. Data were analyzed into two ways.
(1) Overall compliance of CHW to WHO steps of safe injection in the areas of: (a) infection prevention steps and (b) intramuscular injecting steps. (2) Cross tabulations to determine if age, sex and setting or places of giving injection were associated with compliance to WHO safe injection in the above mentioned areas of infection prevention steps and intramuscular injecting steps. In cross tabulation, performance of these steps were quantified and categorized as very well if CHW provided injection to client with all steps complied to WHO safe practise (100% compliance), well for 75-99% and Fair for 50-74% and poor if less than 50%.
Results
A total of 35 CHW were assessed for injection safety steps compliance. Among CHW participated, 8 were aged between 15-24, and 27 aged between 25-45, while 21 of them were male and 14 were female (Table 1 ). There were a total of 1717 DMPA injections administered by CHWs of which all steps were direct observed by Nurses and checklist forms filled: Among the filled forms 13 were excluded due to incomplete information. The total of 1704 forms was included for data analysis.
Overall compliance of CHW to WHO infection prevention steps
In infection prevention steps, majority of injections administered by CHWs complied to WHO practice for safe infection prevention steps ( Table 2) .
The overall percentage of compliance to WHO Infection prevention for each step are indicated below ( 
Cross tabulations to determine if age, sex and setting or places of giving injection were associated with compliance to WHO infection prevention steps
In infection prevention steps, cross tabulation, performances of these steps were quantified and categorized (Table 4 ). The result indicates that when compliance was quantified, about 79% of injection performed by CHW aged between 18-25 years and 77% of injection administered by CHW aged 25 -45 years were done very well (100% compliances with all step collect complied to WHO guideline) (Table 4) . Although the compliance of CHW aged 17 -24 looks higher than 25 -45 years age, but since the confidence intervals overlap each other, then the difference is not significant. The CHW aged 17-24 had no (0%) none compliance to WHO safe steps of injection administration compared to aged 25-45 who had 3.9% non compliance to WHO safe injection (Table 4 ). The highest compliance of infection prevention (Very well) was 94.9% for male compared to 80.5% for female. There is an indication that male performance was better than that of females but the difference was not statistically significant. The none compliance was more for female 4.2% compared to male 1.8%. The result also shows the different in compliance to infection prevention step is significance if injection was conducted at CHW's home than another location. The infection prevention steps compliance based on setting where injection was administered: CHW's home by 90.7%, health centre by 80%, client home by 77% and 59.4% in other settings (Table 4) . Poor infection prevention performance was more observed at other places by 4.5% followed by client home of 3.7% and 0.3% at CHW's home. No non compliance (0-50%) was observed at Health centre setting (Table 4) .
Cross tabulations to determine if age, sex and setting or places of giving injection were associated with compliance to WHO intramuscular injecting steps
In intramuscular injecting, the result indicate that 91% of injections performed by CHW aged 17-24 were very wells (100% complied), while CHW aged between 25-45 administered 82% of intramuscular injection with all steps complied ( Table 5) .
The CHW aged 17-24 had no none compliance performance while aged 25-45 had none compliance of 4% and the difference is statistically significant since the confidence interval doesn't overlap (Table 5 ). The Compliance to intramuscular injecting steps indicate compliance of 91.7% among CHW aged 17-24, and 82.4% of CHW aged between 25-45 , while CHW aged 17-24 had no non compliance (0-50%), while aged 25-45 had non compliance of 4% and the difference is statistically significant since the confidence interval doesn't overlap (Table 5) . Intramuscular Injecting steps compliance by gender of CHW shows that majority complied, but male compliance is higher (88.1%) than female (80.9 and the difference is significant since the confidence intervals don't overlap (Table 5) . Intramuscular injecting steps compliance based on setting where injection conducted indicates that CHW's home performance looks a bit higher than the others ( home 89.6%, health centre, 83.1%, patient home 84% and other places 81%, but the difference is not significant (Table 5) .
Discussion
Community health workers complied to WHO guidelines for safe injection steps that can change health policy to add a new cadre for family planning services in the community setting. CHWs successfully followed infection prevention and intramuscular injection steps as established by WHO.
The objective of this study was to assess CHW compliance to WHO guideline of safe injection steps in community to inform policy makers on the evidence of capability of CHW to take over the task of distributing and administering the most popular and preferred by women injectable contraceptive, DMPA in Tanzania. Safety was addressed through ability of CHW to follow guideline of steps while administering injection. The community health workers in this study reported overall higher compliances to WHO guidelines of safe injection steps while injecting contraceptive. They have demonstrated compliance to infection prevention steps and intramuscular injecting steps as indicator of good training received from health care staffs of the ministry of health. They have demonstrated reliability for task shifting injectable contraceptive from overloaded health care workers to CHW.
WHO infection prevention steps
With respect to WHO compliances on infection prevention steps, CHW aged between 18-25 are more likely to comply with guideline steps compared to CHW aged 25 years and above, while female CHWs are less likely to compliance to the guideline steps compared to male when receiving similar training. The CHWs are more likely to comply to WHO guideline steps to infection prevention when performing their activities at their own home compared to other places that the client may choose to get injection. This result findings may be contributed by the well know environment that CHW is used to provide injection procedure.
WHO intramuscular injecting steps
The majority of CHW complied with WHO guideline for safe intramuscular injecting steps. However young CHWs aged 17-24 are more likely to comply to all guideline if they are well taught and motivated, while at similar situation, CHW aged 25 and above are likely to non-compliance to the guidelines and instructions provided. Male CHWs are more likely to comply compare to their opposite gender. Based on setting where injection was given, CHW's home setting is the best place to help CHW to comply with guideline for intramuscular injecting steps, probably due to privacy and undisturbed environment where service is provided. Further study is needed to evaluate if CHW can provide more advanced long term family planning method of 'implant'.
Conclusion
The study indicated that CHWs can provide safe injection of Depo-provera. The findings help to inform the Ministry of Health that if CHW is well trained and prepared is capable of providing safe family planning services and can even increase access to contraceptives. The Ministry of Health can use this result for policy change and give opportunity to CHW to provide contraceptive services while reducing workload to health facility staffs. 
